Biofrontera
BFRIW
6 hedge funds and large institutions have $8.21K invested in Biofrontera in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.17% less ownership
Funds ownership: 14.39% → 14.22% (-0.17%)
58% less capital invested
Capital invested by funds: $19.3K → $8.21K (-$11.1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$144 |
BFRIW Hedge Fund Activity: Q1 2026 in Review
6 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q1 2026, worth a combined $8.21K — down 58% from $19.3K a quarter earlier.
Fund positioning in BFRIW was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, adding an estimated $5. The largest seller was Susquehanna International Group, cutting an estimated $144.
- 6 institutional investors held Biofrontera (BFRIW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $8.21K of Biofrontera stock for Q1 2026, down 58% quarter-over-quarter.
- 0 funds opened new Biofrontera positions in Q1 2026 and 0 closed out.
- The largest Biofrontera buyer in Q1 2026 was Clear Street, an estimated $5 added.
- The largest Biofrontera seller in Q1 2026 was Susquehanna International Group, an estimated $144 sold.
Based on aggregated 13F filings for Q1 2026.